IL15 and cranioectodermal dysplasia: A recent study evaluated ex vivo the effect of aIL-15, an anti-IL-15 moAb, on the immune response responsible for intestinal epithelial damage from untreated CeD patients’ jejunal biopsies (Ethics committee of the San G. Moscati Hospital, Avellino, Italy, CECN/809) [90].